EF
TARO
Empirical Finance’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-18,913
| Closed | -$1.39M | – | 422 |
|
|
2021
Q1 | $1.39M | Hold |
18,913
| – | – | 0.24% | 107 |
|
|
2020
Q4 | $1.39M | Hold |
18,913
| – | – | 0.24% | 107 |
|
|
2020
Q3 | $1.04M | Buy |
18,913
+164
| +0.9% | +$8.99K | 0.22% | 118 |
|
|
2020
Q2 | $1.25M | Buy |
18,749
+550
| +3% | +$36.6K | 0.32% | 89 |
|
|
2020
Q1 | $1.11M | Buy |
18,199
+8,523
| +88% | +$522K | 0.35% | 79 |
|
|
2019
Q4 | $851K | Buy |
9,676
+115
| +1% | +$10.1K | 0.21% | 112 |
|
|
2019
Q3 | $721K | Hold |
9,561
| – | – | 0.2% | 99 |
|
|
2019
Q2 | $817K | Buy |
9,561
+50
| +0.5% | +$4.27K | 0.22% | 89 |
|
|
2019
Q1 | $1.03M | Sell |
9,511
-4,263
| -31% | -$461K | 0.26% | 76 |
|
|
2018
Q4 | $1.17M | Hold |
13,774
| – | – | 0.35% | 69 |
|
|
2018
Q3 | $1.35M | Hold |
13,774
| – | – | 0.34% | 74 |
|
|
2018
Q2 | $1.59M | Buy |
13,774
+4,263
| +45% | +$493K | 0.4% | 45 |
|
|
2018
Q1 | $1.03M | Sell |
9,511
-557
| -6% | -$60.2K | 0.26% | 76 |
|
|
2017
Q4 | $1.05M | Sell |
10,068
-10,521
| -51% | -$1.1M | 0.35% | 80 |
|
|
2017
Q3 | $2.32M | Buy |
20,589
+10,257
| +99% | +$1.16M | 0.8% | 28 |
|
|
2017
Q2 | $1.16M | Buy |
10,332
+23
| +0.2% | +$2.58K | 0.45% | 65 |
|
|
2017
Q1 | $1.2M | Buy |
10,309
+10,027
| +3,556% | +$1.17M | 0.56% | 39 |
|
|
2016
Q4 | $30K | Buy |
+282
| New | +$30K | 0.02% | 145 |
|